Breathe Well Live Well
|
Efficacy in asthma of once-daily treatment with fluticasone furoate: a …
7thSpace Interactive (press release) Methods: Asthma patients maintained on ICS for [greater than or equal to]3 months with baseline morning forced expiratory volume in one second (FEV1) 50-80% of predicted normal value and FEV1 reversibility of [greater than or equal to]12% and [greater … |
View full post on asthma – Google News
|
Real-World Study Comparing QVAR™ to fluticasone highlights the importance of …
DigitalJournal.com (press release) The study, looking at more than 2000 asthma sufferers treated with QVAR™ or fluticasone in the United Kingdom for one year, revealed that those treated … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Active, not recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Placebo Inhalation Powder; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Placebo Oral Capsule; Drug: Prednisolone Oral Capsule
Sponsor: GlaxoSmithKline
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Fluticasone propionate inhalation powder; Drug: Fluticasone furoate inhalation powder; Drug: Placebo inhalation powder
Sponsor: GlaxoSmithKline
Recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Fluticasone furoate/Vilanterol Inhalation Powder; Drug: Fluticasone Furoate Inhalation Powder; Drug: Placebo Inhaltion Powder
Sponsor: GlaxoSmithKline
Recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Fluticasone furoate 50 mcg (4 inhalations); Drug: Fluticasone furoate 100 mcg (4 inhalations); Drug: Fluticasone furoate 200 mcg (4 inhalations); Drug: Vilanterol 25 mcg (4 inhalations)
Sponsor: GlaxoSmithKline
Not yet recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Formoterol/Fluticasone; Drug: Foraseq®; Drug: Fluticasone
Sponsor: Eurofarma Laboratorios Ltda
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
 UK News Reporter |
Once-Daily Fluticasone Furoate Provides Effective Control in Symptomatic …
DG News BARCELONA — September 20, 2010 — Once-daily fluticasone furoate is well tolerated and provides effective asthma control in symptomatic … New Hope For Asthma Sufferers New Combination for Asthma Shows Encouraging Results in Delivering Efficacy … |
View full post on asthma – Google News
|
QVAR(R) Versus Fluticasone in a Real-World Study Highlights the Importance of …
MarketWatch (press release) Asthma control was achieved in the QVAR population at lower doses of drug versus those in the Flovent population. These results were published in the … |
View full post on asthma – Google News